Louise Rodino-Klapac - President, R&D and Tech Ops at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D and Tech Ops
Stock Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Louise Rodino-Klapac since 10/24/2024

Holdings reported by Louise Rodino-Klapac for Sarepta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 229K $4.59M $20.06 Sep 3, 2025 Direct
Performance Restricted Stock Units 17.5K $2.06M $117.51 Feb 11, 2025 Direct Common Stock
Performance Stock Units 6.25K $0 $100.13 Aug 5, 2025 Direct Common Stock
Stock Options (right to buy) 16.6K Mar 10, 2025 Direct Common Stock

Transactions reported by Louise Rodino-Klapac for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.